Lacidipine

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP02933CAS No. ：103890-78-4Purity：98%

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	103890-78-4	Cat. No.	BCP02933
Name	Lacidipine
Synonyms	Lacipil;Motens;
SMILES
Chemical Name
Formula	C26H33NO6	M. Wt	455.54
Purity	98%	Storage	Store at 4-8°C
Description	Lacidipine (Lacipil, Motens) also inhibits Ca2+ (ER) efflux and enhances folding, trafficking, and activity of degradation-prone GC variants. Lacidipine (Lacipil, Motens) remodels mutated GC proteostasis by simultaneously activating a series of distinct molecular mechanisms, namely modulation of Ca2+ homeostasis, upregulation of the ER chaperone BiP, and moderate induction of the unfolded protein response. However, unlike previously reported proteostasis regulators, lacidipine (Lacipil, Motens) treatment is not cytotoxic but inhibits apoptosis induction typically associated with sustained activation of the unfolded protein response.In another study, lacidipine pre-treatment prevents deterioration of motor nerve conduction velocity as compared to streptozotocin diabetic rats. Hyperalgesia induces by streptozotocin was antagonized by lacidipine (Lacipil, Motens).